Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Nabi Biopharmaceuticals takes part in phase IIb study of NicVAX vaccine

Oct. 29, 2009

Aeolus drug protects gastrointestinal tract in acute radiation syndrome studies

Oct. 26, 2009

Non-selective opioid modulator RDC-5768 reduces behavioral effects of drugs of abuse

Oct. 23, 2009

Novartis reports interim results from phase II trial of Cytos Biotechnology's nicotine vaccine

Oct. 21, 2009

Alkermes reports results from clinical trials of ALKS-33

Oct. 14, 2009

Catalyst to continue development of vigabatrin for cocaine and methamphetamine addiction

Oct. 5, 2009

NIH awards Novelos Therapeutics and MGH grant to study NOV-002 and NOV-205

Oct. 2, 2009

NIAID awards Cleveland BioLabs grant for protectan CBLB-502 research

Sep. 29, 2009

RX-100 shows potential in protecting against lethal whole-body radiation

Sep. 18, 2009

Aeolus initiates second AEOL-10150 study as a countermeasure to radiation

Sep. 17, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026